Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema: Effects on plasma brain natriuretic peptide concentrations

European Heart Journal

Volumn 23, Issue 17, 2002, Pages 1379-1386

  Kelly, C A ^a   Newby, D E ^a   McDonagh, T A ^b   Mackay, T W ^a   Barr, J ^a   Boon, N A ^a   Dargie, H J ^b   Douglas, N J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Heart failure; Natriuretic peptides; Oedema; Oxygen; Ventilation

Indexed keywords

ADRENALIN; BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE; NORADRENALIN;

ACUTE HEART INFARCTION; ADRENALIN BLOOD LEVEL; AGED; ARTICLE; BREATHING RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; FEMALE; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORADRENALIN BLOOD LEVEL; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY ACIDOSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; OXYGEN INHALATION THERAPY; POSITIVE-PRESSURE RESPIRATION; PULMONARY EDEMA; TREATMENT OUTCOME;

EID: 0036760436     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3156     Document Type: Article

References (36)

1. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-8.
2. Stauffer JL, Olsen DE, Petty TL. Complications and consequences of endotracheal intubation and tracheostomy: A prospective study of 150 critically ill patients Am J Med 1980; 70: 65-76.
3. Katz JA, Marks JD. Inspiratory work with and without continuous positive airway pressure in patients with acute respiratory failure Anesthesiology 1985; 63: 598-607.
4. Naughton MT, Rahman A, Hara K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressure in patients with congestive heart failure Circulation 1995; 91: 1725-31.
5. Lenique F, Habis M, Lofaso F, Dubois-Rande J-L, Harf A, Brochard L. Ventilatory and haemodynamic effects of CPAP in left heart failure Am J Respir Crit Care Med 1997; 155: 500-5.
6. Baratz DM, Westbrook PR, Shah PK, Mohsenifar Z. Effect of nasal CPAP on cardiac output and oxygen delivery in patients with congestive heart failure Chest 1992; 103: 1397-1401.
7. Bernsten AD, Holt AW, Vedig AE, Skowronski GA, Baggoley CJ. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask N Engl J Med 1991; 325: 1825-30.
8. Rasanen J, Heikkila J, Downs J, Nikki P, Vaisanen I, Viitanen A. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema Am J Cardiol 1985; 55: 296-300.
9. Lin M, Yang YF, Chiang HT, Chang M-S, Chiang BN, Cheitlin MD. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema: Short term results and long term follow up. Chest 1995; 107: 1379-86.
10. Mehta S, Jay GD, Woolard RH et al. Randomized, prospective trial of bi-level versus continuous positive airway pressure in acute pulmonary oedema Crit Care Med 1997; 25: 620-8.
11. Masip J, Betbese AJ, Paez J et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: A randomised trial Lancet 2001; 356: 2126-32.
12. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to haemodynamic abnormalities in congestive heart failure Am J Cardiol 1982; 49: 1659-66.
13. Francis GS, Benedict C, Johnstone DE et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure Circulation 1990; 82: 1724-9.
14. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality Circulation 1990; 82: 1730-6.
15. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 1994; 90: 195-203.
16. Wei C-M, Heublein DM, Perella MA et al. Natriuretic peptide system in human heart failure Circulation 1993; 88: 1004-9.
17. Yu CM, Sanderson JE. Plasma brain natriuretic peptide - An independent predictor of cardiovascular mortality in acute heart failure Eur J Heart Failure 1999; 1: 59-65.
18. Tsutamoto T, Wada A, Maeda K et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 1997; 96: 509-16.
19. Heublin DM, Heser DW, Edwards BS et al. N-terminal (1-25) atrial natriuretic factor in human congestive heart failure: A marker for endogenous secretion J Am Coll Cardiol 1989; 13: 9A.
20. Goldstein DS, Feuerstein G, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electromechanical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981; 28: 467-75.
21. Bellenger NG, Burgess MI, Ray SG et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000; 21: 1387-96.
22. Kelly C, Newby DE, Boon NA, Douglas NJ. Support ventilation versus conventional oxygen Lancet 2001; 357: 1125-7.
23. Sacchetti AD, Harris RH, Paston C, Hernandez Z. Bi-level positive airway pressure support system use in acute congestive heart failure: Preliminary case series Acad Emerg Med 1995; 2: 714-18.
24. Pollack CV, Torres MT, Alexander L. Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department Ann Emerg Med 1996; 27: 189-92.
25. Kelly AM, Bau S, Georgakos C, Rosengarten P. Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema Aust NZ J Med 1997; 27: 319-22.
26. Sharon A, Shpirer I, Kaluski E et al. High-dose intravenous isosorbide dinitrate is safer than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema J Am Coll Cardiol 2000; 36: 832-7.
27. Takeda S, Takano T, Ogawa R. The effect of nasal continuous positive airway pressure on plasma endothelin-1 concentrations in patients with severe cardiogenic pulmonary edema Anesth Analg 1997; 84: 1091-6.
28. Rusterholz T, Kempf J, Berton C et al. Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema Intensive Care Med 1999; 25: 21-8.
29. Qi W, Kjekshus J, Hall C. Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs Scand J Clin Lab Invest 2000; 60: 55-63.
30. Lazzeri C, Franchi F, Porciani C et al. Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension Am J Hypertens 1995; 8: 799-807.
31. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993; 341: 1109-13.
32. Omland T, Aakvaag A, Bonarjee VVS et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after acute myocardial infarction Circulation 1996; 93: 1963-9.
33. Sumida H, Yasue H, Yoshimura M et al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol 1995; 25: 1105-10.
34. Morita E, Yasue H, Yoshimura M et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 1993; 88: 82-91.
35. Cohn JN, Levine TB, Olivari MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 1984; 311: 819-23.
36. Missouris CG, Grouzmann E, Buckley MG, Barron J, MacGregor GA, Singer DR. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines Clin Sci 1998; 94: 591-9.